Getting press coverage now. See proactive investors link below:
http://www.*.com.au/companies/news/...-on-the-podium-of-asx-top-gainers-183942.html
Patrys Ltd's (ASXAB) shares are up 75% in morning trade at $0.007, following positive pre-clinical data for its lead drug candidate PAT-DX1, a novel first-in-class drug candidate being developed to treat a range of different cancers.
Studies in multiple pre-clinical models of cancer have demonstrated the ability of Patrys’ proprietary humanized antibody, PAT-DX1 to be taken-up and to kill cancer cells.
This confirms the successful humanization and de-immunization of 3E10-derived antibody fragments with conserved structural properties and enhanced in vitro activity.
- Forums
- ASX - By Stock
- PAB
- Ann: PAT-DX1 Active in Pre-clinical Cancer Models
Ann: PAT-DX1 Active in Pre-clinical Cancer Models, page-23
-
-
- There are more pages in this discussion • 131 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $428 | 61.16K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 154511 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 1880092 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 154511 | 0.007 |
16 | 5482389 | 0.006 |
15 | 7215158 | 0.005 |
8 | 5514000 | 0.004 |
7 | 6399016 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 1880092 | 4 |
0.009 | 1133332 | 2 |
0.010 | 557000 | 3 |
0.011 | 1000000 | 1 |
0.012 | 1558283 | 5 |
Last trade - 14.20pm 30/07/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online